Prolene
Device Hernia
PDI 10705031203341
General payments
$38,815
Research payments
$96,512
Through program year 2025, $38,815 in general payments and $96,512 in research payments were reported against Prolene (Hernia).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $18,239 | 36 |
| 2025 | Research | $7,550 | 10 |
| 2024 | General | $6,328 | 4 |
| 2024 | Research | $5,736 | 10 |
| 2023 | General | $2,510 | 2 |
| 2023 | Research | $34,198 | 15 |
| 2022 | General | $9,894 | 13 |
| 2022 | Research | $35,028 | 10 |
| 2021 | General | $1,843 | 18 |
| 2021 | Research | $14,000 | 2 |
Breakdown
The top 5 of 28 recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
73 general · 47 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.